Skip to content

Life Sciences

AI that turns life sciences data into operational advantage

Research, clinical, manufacturing, and regulatory data all sit in different systems, and Datafi connects them into one governed operating context every team can act on.

Life sciences organizations aren't short on data. AI initiatives stall because R&D, clinical, manufacturing, and regulatory data live in separate worlds, and the teams who need context can't assemble it fast enough.

Fragmented Data Across the Drug Lifecycle

Research platforms, CTMS, EDC, LIMS, ERP, QMS, and submission systems each hold a piece of the story, so scientists, clinical ops, and regulatory teams never see the whole picture.

Every Analysis Requires Manual Reconciliation

Researchers, clinical teams, and quality teams spend hours or days gathering context before analysis can begin, which turns data science into a permanent bottleneck.

AI Experiments That Stall in Regulated Environments

Pilots summarize documents but never reach the full R&D-to-market context, and generic tools can't enforce GxP, IP protection, or auditability.

The Operating System

An operating system that connects the full drug lifecycle

A vertically integrated data and AI stack that provides trusted scientific context, GxP-aligned governance, and an interface that life sciences teams actually adopt.

100+ sources

Connected

Research, clinical, manufacturing, regulatory, and commercial data unified in a single operating context

100% auditable

By Design

Role-based access, audit trails, and policy enforcement across every AI interaction with regulated data

Every role

Enterprise Wide

Scientists, clinical ops, regulatory affairs, quality directors, and supply chain leaders

Hours→ minutes

Context Assembly

From manual data reconciliation across systems to instant, governed access grounded in complete scientific and operational context

Agentic Workflows

AI agents built for the complexity of life sciences

End-to-end workflows that aggregate data across the drug lifecycle, detect signals, reason across regulated systems, and deliver tangible scientific and operational artifacts that are governed, auditable, and IP-protected.

Clinical Trial Monitoring · End-to-End Agentic Workflow Continuous monitoring from data collection to risk-scored trial brief STEP 1 Trial Data Collected STEP 2 AI Aggregates Sites STEP 3 Detects Deviations STEP 4 Safety Signal Check STEP 5 Risk Scoring OUTPUT Trial Status Brief CONNECTED DATA SOURCES CTMS EDC Safety DB Site Reports Protocol Regulatory Docs Enterprise Policies Applied GxP-Aligned • Full Audit Trail • Role-Based Access • IP Protection RESULT: Trial status brief with risk scores ready in 12 minutes (was 2+ days of manual data assembly)

Research Synthesis Brief

Compound history, literature synthesis, and competitive context assembled for portfolio review

Trial Status Report

Risk-scored trial brief with site performance, enrollment, and safety signal analysis

Quality Disposition Report

GxP-compliant batch review with out-of-trend detection and CAPA tracking

Regulatory Evidence Package

Audit-ready submission dossier with governed evidence and gap analysis

Use Cases

Autonomous agents for high-impact life sciences workflows

Each workflow delivers a tangible artifact: a research synthesis brief, a trial status report, a quality disposition or a regulatory evidence package. Every one is governed, auditable and ready for action.

Drug Development & Research Acceleration

Give every researcher superhuman access to scientific context

Compound prioritization, target validation, and biomarker selection each require pulling internal research platforms, external literature, and prior study results together, which takes days by hand. Datafi runs that assembly as an agentic workflow and returns a research synthesis brief ready for portfolio review.

Compound and target data aggregation from internal research systems

Literature synthesis and competitive program monitoring

Biomarker and clinical signal analysis across prior studies

Research synthesis briefs generated and ready for portfolio review

Compound Research Network AI-synthesized • Full scientific context DFI- 2847 Target JAK2 Biomarker IL-6, CRP Prior 12 studies Literature 847 papers Competitive 6 programs Research Synthesis Brief Target validated • Literature synthesized • Ready for portfolio review
Trial Monitoring Dashboard Real-time site performance • Safety signal tracking Site Performance (Enrollment vs. Target) Site 001 · Boston 90% Site 002 · London 78% Site 003 · Tokyo 52% Site 004 · Berlin 31% Protocol Milestones FPI 50% Enroll ! 75% Enroll LPI DB Lock AI Risk Alert: Sites 003 & 004 below enrollment target Recommend protocol amendment review and site boost strategy for at-risk locations Trial Status Brief Generated Risk-scored • Site-level breakdown • Action items

Clinical Trial Operations & Monitoring

Monitor every trial with full operational context

Protocol adherence, site performance, enrollment pacing, safety signals, and data quality flags sit in separate systems, and a delay at any stage costs millions. Datafi agents monitor the full trial picture continuously and produce status briefs that surface risk before it escalates.

Real-time site performance monitoring with enrollment and milestone tracking

Safety signal detection and adverse event pattern recognition

Protocol deviation flagging with root cause context

Trial status briefs with risk flags generated for clinical leadership

Enterprise-Wide Impact

Every role in life sciences, operating with superhuman ability

Every team gains the ability to reason across the full scientific and operational context, run multi-step workflows, and produce real outcomes.

Head of R&D

Accelerates portfolio decisions with compound history, literature, and clinical signal synthesis assembled automatically

VP Clinical Operations

Monitors every trial in real time with AI-generated risk briefs that surface issues before they escalate

Regulatory Affairs Director

Assembles submission evidence in hours with governed, traceable data pulled from across the enterprise

Quality Director

Catches out-of-trend quality signals early with continuous monitoring and AI-generated disposition reports

Supply Chain Director

Ensures supply continuity with real-time visibility across supplier compliance, inventory, and demand signals

Enterprise Benefits

Why life sciences organizations choose Datafi

AI in life sciences must earn trust before it can earn adoption. Datafi connects the full data ecosystem across the drug lifecycle, enforces enterprise policies, and protects IP.

The result is AI that participates in real workflows, from compound prioritization to submission readiness, not isolated pilots that never scale.

GxP & IP-Aligned Governance

Role-based access, audit trails, and enterprise policy enforced at the platform level on every AI interaction with regulated data.

Full Lifecycle Context

R&D, clinical, manufacturing, quality, regulatory, and commercial data connected in one operating context, with no manual reconciliation.

Adopted by Non-Technical Teams

A conversational interface built for scientists, clinical ops, and regulatory teams, with no SQL or dashboards required.

Outcomes

The operational impact life sciences leaders measure

Pharma and biotech organizations that deploy Datafi stop treating AI as a research curiosity and start treating it as operational infrastructure: faster portfolio decisions, shorter trial timelines, and submissions that don't slip.

Accelerate Drug Development Timelines

Datafi compresses days of compound history, literature, and competitive research into minutes, so go/no-go decisions happen while the evidence is still fresh.

Catch Trial Risks Before They Cost Months

Continuous monitoring of enrollment pacing, protocol deviations, and safety data produces risk-scored trial briefs while there's still time to act.

Assemble Regulatory Submissions in Hours, Not Months

Datafi gathers evidence across clinical, manufacturing, safety, and quality systems and produces governed, traceable submission packages on demand.

Build AI into your life sciences operating model

A practical, scalable path to faster drug development, smarter clinical operations, stronger manufacturing quality, and proactive regulatory readiness, powered by an operating system for business AI.

Interested in investing in Datafi?